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1. Introduction 
Adenylate cyclase activity in vitro can be stimula- 
ted by hormones, prostaglandins, and NaF. NaF acti- 
vates the enzyme from all tissues by a mechanism that 
is still not understood [1] and the E series of prosta- 
glandins can either stimulate, inhibit, or have no effect 
on adenylate cyclase activity [2,3]. Attempts to puri- 
fy adenylate cyclase from membranes by solubiliza- 
tion usually result in the loss of stimulation by hormo- 
nes and prostaglandins, the solubilized enzyme being 
activated only by NaF [4]. 
We have been attempting to purify adenylate cy- 
clase from mouse parotid gland, a tissue that has 
high basal adenylate cyclase activity [5]. In the course 
of these studies we observed that both the particulate 
and the solubilized enzyme xhibited adependence 
on Ca 2+ ion. This property, along with activation 
by NaF, may be of value in elucidating the mechanism 
of action of adenylate cyclase, since the effects appear 
to be manifest directly on the catalytic unit of the 
enzyme. 
2. Materials and methods 
Adenylate cyclase activity was determined by mea- 
suring the conversion of ATP t~32p into cAMP 32p 
during 10 min incubation at 37 ° C in a reaction mix- 
ture containing 25 mM Tris-HC1 (pH 7.5), 6 mM 
MgC12, 1 mM EDTA, 3 mM mercaptoethanol, 5 mM 
cAMP, ATP ct32p (lmM and 10-20 dpm/pmole), 
0.0075% bovine serum albumin, an ATP regenera- 
tion system consisting of 5.4 mM phosphoenolpyru- 
vate and 2.5 units pyruvate kinase, and 0.1-0.2 mg of 
enzyme protein in a total vol of 0.1 ml. 
Reactions were terminated by the addition of 0.1 ml 
40 mM Tris-HCl (pH 7.5), 40 mM ATP and 12.5 mM 
cAMP 3H (10 000 cpm). cAMP was isolated on 
columns of neutral alumina [6] with a recovery of 
90-95%. The reaction rate was linear with time and 
with protein concentration under the assay conditions 
used. 
3. Results 
Homogenates of parotid gland demonstrated high 
basal adenylate cyclase activity that was stimulated 
2-fold by 0.1 mM isoproterenol (IPR) and 4-fold by 
10 mM NaF (fig. 1.). Enzyme activity was dependent 
on Mg2+ in a manner characteristic of adenylate cy- 
clase from other tissues [7,8], demonstrating optimal 
activity when the Mg2+ concentration was 5 times 
that of ATP. 
Ethylene glycol bis (13 aminoethyl ether) NN'-tetraa- 
cetic acid (EGTA), a chelator of calcium, progressively 
inhibited enzyme activity at concentrations ranging 
from 0.05-1.0 mM (fig. 1.). Inhibition was maximal 
at 0.5 mM EGTA; basal, IPR and NaF stimulated 
activities were inhibited to the same extent. The inhi- 
bition could be reversed by the addition of CaC12 ;
activity returned to normal when the calcium ion 
concentration was equimolar with that of EGTA (fig. 
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Fig. 1. Effect of increasing concentrations of EGTA on ade- 
nylate cyclase activity of mouse parotid homogenate. NaF 
concentration was 10 mM and IPR was 0.1 mM. Assays were 
carried out using 100 t~g of protein. Each point represents 
the mean _+ S.E. of at least 3 determinations. 
2A). Since EGTA is not totally specific for calcium 
it is possible that the addition of calcium could dis- 
place some other divalent cation that is present at 
very low concentrations. However, because there is a 
high concentration f calcium in the parotid [9], this 
ion seems the most likely candidate. Furthermore the 
response of adenylate cyclase to calcium is biphasic 
(fig. 2B); 0.1 mM CaCI2 caused a statistically signifi- 
cant (p < 0.1) increase in both basal and stimulated 
enzyme activity and pronounced inhibition above 
0.5 mM. 
Calcium is not required for hormonal activation 
of the enzyme as in other tissues [10], since IPR 
stimulates parotid adenylate cyclase in the presence 
of EGTA. The calcium dependence of parotid adeny- 
late cyclase seems to involve a requirement for calcium 
at the catalytic site of the enzyme. This was confirmed 
by homogenizing parotid tissue in Lubrol-PX, a non- 
ionic detergent previously used by Levey to solubilize 
myocardial adenylate cyclase [4]. Enzyme solubilized 
by this procedure demonstrated high basal activity and 
was stimulated by NaF but not by IPR. The solubilized 
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Fig. 2. (A) Effect of the addition of C aCI 2 to adenylate cyclase 
assayed in the presence of 0.5 mM EGTA. Control refers to 
determinations made in the absence of EGTA and CaCI 2. 
(B) Activity of parotid adenylate cyclase in the presence of 
increasing concentrations of CaCI 2. The concentrations of 
NaF and IPR were the same as in fig. 1. 
adenylate cyclase showed the same calcium dependence 
as did the wholly particulate nzyme (table 1), but it 
was not stimulated by low concentrations of calcium 
ion alone suggesting a possible additional role for cal- 
cium as a coupler between hormone receptor and ca- 
talytic unit. 
4. Discussion 
Inhibition of adenylate cyclase by calcium has been 
demonstrated in preparations from a number of tissues 
[11], while stimulation by calcium has been reported 
only for the brain enzyme [12]. We have found that 
EGTA did not affect adenylate cyclase from mouse 
liver and kidney, while enzyme from whole mouse 
brain was inhibited in a manner identical to the paro- 
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Table 1 
Adenylate cyclase pmoles/mg protein/10 min in presence of 
No 0.5 mM 0.5 mM EGTA 10 mM 10 mM NaF 10 mM NaF 
Tissue addition EGTA + NaF 0.5 mM EGTA 0.5 mM EGTA 
0.5 mM CaC12 0.5 mM CaC12 
Liver ND ND ND 540 -+ 44 594 -+ 30 ND 
Kidney 56 +- 4 48 -+ 5 ND 659 -+ 6 632 +- 23 ND 
Brain 1090 +- 60 520 -+ 10 1080 ± 20 5520 ± 130 3570 ± 50 4940 ± 100 
Parotid 366 ± 14 209 ± 18 313 ± 12 804 +- 56 403 ± 34 660 -+ 98 
Parotid + 
Lubrol 336 ± 14 133 -+ 4 312 ± 10 615 ± 29 302 ± 11 535 +- 33 
Effect of EGTA and EGTA + CaCI 2 on basal and NaF stimulated activities of adenylate cyclase prepared from various mouse 
tissues. Values are mean ± S.E. of at least hree determinations. ND indicates measurements ot made. Because of the low acti- 
vity in homogenates, adenylate cyclase was assayed in 2000 g pellets of liver and kidney. Parotid adenylate cyclase was solubi- 
lized by homogenization in 1% Lubrol PX and enzyme was assayed in the 20 000 g supernatant. 
tid enzyme (table 1). Adenylate cyclase from calf cere- 
bral cortex has been shown by Bradham, et al. [13] to 
be inhibited by EGTA, enzyme activity being restored 
by the addition of Ca 2+ or St2+. Johnson and 
Sutherland [14] recently showed that solubilized 
adenylate cyclase from rat cerebellum has a require. 
ment for metal ions other than Mg2+. 
In both parotid and brain, calcium stimulates 
adenylate cyclase by a hormone independent mecha- 
nism since solubilized enzyme from both tissues is 
inhibited by EGTA. NaF and calcium are thus the 
only known agents besides ATP and Mg2+, to direct- 
ly affect the catalytic unit of adenylate cyclase. 
It would seem that brain and parotid adenylate cy- 
clases are unique in several respects: 1) Both tissues 
display unusually high basal enzyme activities; 2) 
the enzymes are inhibited by EGTA; 3) during diffe- 
rential centrifugation the enzymes ediment at g 
forces in excess of 10 000g × 10 min; 4) both enzy- 
mes are refractory to prostaglandin E 1 . 
An increase in membrane permeability to calcium 
ion is an early event occurring in many tissues that 
respond to an increase in the level of cAMP. Conse- 
quently it has been postulated that both cAMP and 
calcium are required for initiation of the physiologic 
response [15]. This is certainly the case in endocrine 
and exocrine glands in which Ca 2+ is required for 
secretion [16]. Though the calcium concentrations 
used in this study are in excess of known physiolo- 
gical concentrations, onedoes not know the local 
Ca2+ concentration i  the vicinity of adenylate 
cyclase. It is possible that calcium ion may regulate 
adenylate cyclase activity in vivo as has been sugges- 
ted for the enzyme from cardiac muscle [17]. In 
the parotid, amylase and calcium are concentrated 
in the zymogen granules and are both secreted in 
response to IPR [9]. After differential centrifuga- 
tion in 0.25 M sucrose containing 10 mM MgC12, 
amylase and adenylate cyclase sediment in the same 
fraction (D.J. Franks, unpublished observation). 
Hence prior to amylase secretion adenylate cyclase 
could be exposed to high local calcium concentra- 
tions which would fall immediately after secretion 
and 'switch off' the enzyme. 
Clearly, further studies are necessary to fully elu- 
cidate the role of cAMP and Ca2+ in the IPR stimu- 
lated parotid. 
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